Advertisements



We are Sorry, This Page doesn't Exist


Biotech Analysis Central Pharma News: Allergan"s CRL, Tonix Pharmaceutical"s Potential Reversal, AstraZeneca"s Tagrisso Win

Biotech Analysis Central Pharma News: Allergan"s CRL, Tonix Pharmaceutical"s Potential Reversal, AstraZeneca"s Tagrisso Win.....»»

Category: topSource: seekingalphaAug 24th, 2018

Celgene says study shows revlimid demonstrated improvement in PFS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 23rd, 2018

This Kansas City highway is one of the deadliest roads in the US, new analysis shows

This Kansas City highway is one of the deadliest roads in the US, new analysis shows.....»»

Category: topSource: yahoo1 hr. 45 min. ago

Analysis: Gazprom loss shows struggle to fill EU gas sales gap with China

Analysis: Gazprom loss shows struggle to fill EU gas sales gap with China.....»»

Category: topSource: yahoo13 hr. 57 min. ago

Seattle ranks near bottom of post-pandemic recovery index

A new analysis shows which downtowns are winning the post-pandemic comeback. Here's how downtown Seattle stacks up......»»

Category: topSource: bizjournalsApr 17th, 2024

J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play

Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a $171.95 price target and potential 37.15% upside. read more.....»»

Category: blogSource: benzingaApr 15th, 2024

Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study

New data from Phase 1/2 study of GTX-102 for Angelman syndrome shows rapid and sustained improvement in patients, exceeding natural history data. read more.....»»

Category: blogSource: benzingaApr 15th, 2024

These are the soft skills most in demand for highly paid jobs

In the ever-evolving workplace landscape, a shift is underway that is redefining what companies value most in potential job candidates, a recent analysis from CashNet USA shows. While technical acumen once reigned supreme, today employers are placing a.....»»

Category: topSource: bizjournalsApr 12th, 2024

Downtown Dallas" comeback ranks No. 1 in Texas, near top of the charts nationally

A new analysis shows which downtowns are winning the post-pandemic comeback. Here's how downtown Dallas stacks up, according to an exclusive analysis by The Business Journals......»»

Category: topSource: bizjournalsApr 11th, 2024

Stock market today: Indexes edge higher after CPI-led rout as wholesale inflation shows improvement

US stocks trimmed losses Thursday after a big sell-off in the prior session, as a key inflation gauge rose less than anticipated in March. Stocks rose after PPI rose less than expected in March.Drew Angerer / Getty US stocks rose were mostly higher.....»»

Category: smallbizSource: nytApr 11th, 2024

Annovis jumps after Alzheimer"s drug shows 30% cognitive improvement in study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2021

Annovis Bio"s Stock Trading Higher As Alzheimer"s/Parkinson"s Candidate Shows Cognitive Improvement

read more.....»»

Category: blogSource: benzingaMay 21st, 2021

New Five-Year Data Shows Durable Efficacy Of AstraZeneca"s Fasenra For Asthma Treatment

read more.....»»

Category: blogSource: benzingaMay 19th, 2021

: Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows

Mixing doses of COVID-19 vaccines increases the risk of mild to moderate side effects when compared with administering two shots of the same vaccine, according to a U.K. trial......»»

Category: topSource: marketwatchMay 13th, 2021

Single Shot Of AstraZeneca, Pfizer COVID-19 Vaccines Provide 87% Protection, South Korea Study Shows: Reuters

read more.....»»

Category: blogSource: benzingaMay 5th, 2021

Ocugen jumps 27% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen in Brazil, the UK, and India. lechatnoir/Getty Images Shares of Ocugen jumped 27% on Monda.....»»

Category: topSource: businessinsiderMay 3rd, 2021

Ocugen jumps 20% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen in Brazil, the UK, and India. lechatnoir/Getty Images Shares of O.....»»

Category: smallbizSource: nytMay 3rd, 2021

AstraZeneca PLC Stock Shows Every Sign Of Being Fairly Valued

Related Stocks: AZN,.....»»

Category: dealsSource: nytMay 1st, 2021

AstraZeneca"s Tagrisso recommended in E.U. for treatment of EGFR lung cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

Top Republicans who challenged election results rake in campaign cash, as individual donations boom

Despite corporate bans, a Washington Post analysis shows that at least a third of the 147 Republicans who challenged the election, raised more campaign money compared to the same period in 2019......»»

Category: topSource: washpostApr 21st, 2021